How to Buy Denali Therapeutics (DNLI) Stock, Explained

denali therapeutics

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201, which has completed phase 1b clinical trials, and DNL151, which is in phase 1 and phase 1b clinical trials for Parkinson’s disease . It is also developing candidates for receptor-interacting serine/threonine protein kinase 1 (RIPK1) products, such as DNL747, a small-molecule brain-penetrating selective inhibitor, RIPK1 inhibitor candidate that is in a trial. phase 1b clinical trial for Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). Besides, Company Develops Enzyme Delivery Vehicle: Iduronate 2-sulfatase, an enzyme replacement therapy program for MPS II, a lysosomal storage disorder; antibody transport vehicle (ATV): program for alpha-synuclein (aSyn), a protein that spreads throughout the brain in Parkinson’s disease; ATV: receptor activator expressed in myeloid cells 2, a therapeutic candidate designed to rescue microglial function in Alzheimer’s disease; and ATV: Tau, a treatment aimed at the spread of Tau. Denali Therapeutics Inc. has a collaboration agreement with Takeda Pharmaceutical Company and Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges MBH, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, Centogene, and MedGenome Labs Private Ltd; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. develop antisense therapies in the field of neurodegenerative diseases. The company was previously known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is based in South San Francisco, California.

How to Buy Denali Therapeutics (DNLI) Stock, Explained

Do you want to learn how to buy Denali Therapeutics (DNLI) shares on Nasdaq in a simple way and through a regulated and reliable broker? Does it surprise you to be able to invest your profits every month and get a return on the stock market? In this tutorial I am going to show you how you can sign up for DEGIRO , a reliable and low commission Dutch investment broker, and how you can get your first shares of Denali Therapeutics Inc. (DNLI) (DNLI) quickly and easily.

What we will do is simple :

  • To start we will create an account in Degiro, a broker platform where we will buy shares of Denali Therapeutics Inc. (DNLI) (DNLI).
  • In 2nd place we will enter €€€ and thus execute our first investment in the stock market.
  • When we visualize the funds, what we will do is locate the company Denali Therapeutics through the ticker, which is DNLI.
  • To finish we are only going to add the number of shares we want to buy, the value and type of order.

This tutorial may have been too essential for you, so I will summarize the purchase process with images.

Degiro registration tutorial.

First we are going to register in Degiro from the following link :

buy shares of Denali Therapeutics Inc. (DNLI)

It will ask us for an email, a username and a password to enter, and then we must continue using the link that they have sent us by mail.

Soon DEGIRO will ask us for the necessary information to approve our identity card . We must have in hand the passport number, ID or driving license, our telephone number and the number of the bank account that we will place to proceed to make our 1st deposit. If you don’t understand how this format works, you can check this simple tutorial on how to use it that we have created at Educacep .

stock Denali Therapeutics

Once our account is approved we will have to enter money from the Deposit / Withdraw tab. We will be able to carry out a transaction that will take between one to two days, or carry out the deposit quickly thanks to Sofort, a totally secure and 100% reliable payment gateway.

transfer money bank Denali Therapeutics

How to buy Denali Therapeutics (DNLI) stock via degiro

Once we have the money we have the possibility of obtaining our 1st share. You can either go to the “Place Order” button in the right corner or select the DEGIRO search engine and type in the ticker. In the following screenshot you will see that I have used the Amazon ticker but you should put (DNLI), the Denali Therapeutics ticker. As we are talking about an action, we will notice that the related tickers are listed and there we will discover to find Denali Therapeutics. The most fundamental thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Denali Therapeutics Inc. (DNLI) is listed on Nasdaq. This step is essential so do not make mistakes.

Denali Therapeutics expensive american bag

When developing the order we have to pay special attention to the next . We will be able to place a limit or market order. Suppose you want to buy a share of Denali Therapeutics at 61.59, but its current price is quite high. With a limit order we will put the value at which we wish to make the acquisition and until there are no shares selling at that value, the acquisition of the share will not be executed. With a market order, you will buy the number of shares that we have adjusted to today’s selling price, which would be closely related to today’s trading price.

stock limited sale order Denali Therapeutics Inc. (DNLI)

In both cases it is convenient that you look at the order: permanent or of the day . As an example, in Spain, the stock market is in the morning and until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If the order is permanent, it will continue until the moment it can be executed, but if you choose the “of the day” option, at the moment the session ends, if it has not been carried out, it will be deleted from your Activity file – Orders in pending status.

I hope this short post will help you invest in Denali Therapeutics. Bye now!

  Company information
  • Denali Therapeutics Inc. (DNLI) Address: 161 Oyster Point Boulevard 2nd Floor South San Francisco, CA 94080 United States 650866 8548 Website: http://www.denalitherapeutics.com
  • Ticker: DNLI
  • Sector: The sector is unknown
  • Industry: Industry
  • Number of employees: 291
  • Listed market: Nasdaq
  • Value last year: $61.59

company executives

Name Title Payment exercised Year of birth
Dr. Ryan J. Watts Ph.D. Co-Founder, President, CEO and Director 1.25 million N/A 1976
Dr. Alexander O. Schuth MD Co-Founder, COO and Sec. 820.32k N/A 1973
Dr Marc Tessier-Lavigne Co-Founder, Chairman of the Scientific Advisory Board and Independent Director 59.5km N/A 1960
Mr Steve Edward Krognes CFO and Treasurer 882.96k N/A 1968
Dr Carole Ho Medical director and director of development. 835.08k 1.88 million 1973
Mr. Tyler M. Nielsen Vice President of Corp. Fin. N/A N/A 1978
Dr. Dana Andersen Technical and Manufacturing Director N/A N/A N/A
Mr Joe Lewcock Scientific Director N/A N/A N/A
Dr Laura Hansen Vice President of Investor Relations N/A N/A N/A
Mr Chris Walsh Associate General Counsel N/A N/A N/A

Recent Denali Therapeutics Events:

Recent Events June 08, 2020 Filed Complete 8-K: Submission of Matters to Vote by Security Holders, Financial Statement May 07, 2020 Filed Complete 8-K: Results of Operations and Financial Condition May 07, 2020 Filed Complete 10- Q: Quarterly Report April 02, 2020 Filed Complete 8-K: Results of Operations and Financial Condition February 27, 2020 Filed Complete 8-K: Results of Operations and Financial Condition